| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180832 Sustained peptide-release formulation |
| 09/16/2004 | US20040180338 Mutated eukariotic transalation initiation factor 2 alpha kinase3, eif2ak3, in patients with neonatal insuluin-dependant diabetes and multiple epiphyseal dyslapsia (wolcott-rallison syndrome) |
| 09/16/2004 | CA2517953A1 Novel gene relating to fibrotic conditions |
| 09/15/2004 | EP1457493A1 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456374A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 09/15/2004 | EP1456212A1 6-aminomorphinane derivatives, method for the production and use thereof |
| 09/15/2004 | EP1456210A1 Pyrazolyl-substituted triazoloquinoxalines |
| 09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
| 09/15/2004 | EP1456205A1 Imidazoquinoline derivatives |
| 09/15/2004 | EP1456204A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1456160A2 Vitamin d analogues |
| 09/15/2004 | EP1455810A1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 09/15/2004 | EP1455791A1 Method for administering birb 796 bs |
| 09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/15/2004 | EP1455776A1 A non-arrhythmogenic metabolite of oxybutynin |
| 09/15/2004 | EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them |
| 09/15/2004 | EP1455697A1 Vaginal delivery of drugs |
| 09/15/2004 | EP1363902B1 Chemical compounds |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP1173440B1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 09/15/2004 | EP1133487B1 Antioxidants |
| 09/15/2004 | EP1133467B1 Ion channel modulating agents |
| 09/15/2004 | EP0841937B1 Use of betaglycan to reduce scarring |
| 09/15/2004 | EP0656786B1 Use of isoflavone phyto-oestrogen extracts of soy or clover |
| 09/15/2004 | CN1529706A 哌嗪衍生物 Piperazine derivatives |
| 09/15/2004 | CN1529697A Tricyclic compounds useful as angiotensin II agonists |
| 09/15/2004 | CN1529692A N-arylphenylacetamide derivatives and medicinal compositions containing same |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529598A Method of treating demyelinating diseases or conditions |
| 09/15/2004 | CN1529578A Use of gourd oil for inhibiting s alpha-reductase activity |
| 09/15/2004 | CN1528418A Chinese medicine for treating pelvis, nephritis and kidney injury and preparing method thereof |
| 09/15/2004 | CN1528392A Capillary artemisia -cape jasmine-rhubarb lyophilized powder injection with therapeutic hepatitis activity and preparing method thereof |
| 09/15/2004 | CN1528376A Chinese medicine for treating chronic nephritis and chronic renal insufficiency |
| 09/15/2004 | CN1528358A Use of plant spearmint for preparing medicine for treating urinary system inflammation and hemorrhagic diseases |
| 09/15/2004 | CN1528338A Thunder godvine multi-aglycone drop pill and preparing method thereof |
| 09/15/2004 | CN1528316A Finasteride drop pill and preparing method thereof |
| 09/15/2004 | CN1528312A Doxazosin mesylate drop pill and preparing method thereof |
| 09/15/2004 | CN1528311A Terazosin Hydrochloride drop pill and preparing method thereof |
| 09/15/2004 | CN1528305A Radix sen rhizoma fibraureae extract drop pill and preparing method thereof |
| 09/15/2004 | CN1166654C Benzoylguanidine derivatives wit advantageous properties, method for producing them and their use in production of medicaments |
| 09/15/2004 | CN1166407C Application of agrose in preparing medicine for prostate hyperplosia |
| 09/15/2004 | CN1166390C Composite Chinese medicine for treating prostatitis |
| 09/15/2004 | CN1166382C Chinese herb. medicine composition for treating diabetes and nephropathy and its preparing method |
| 09/15/2004 | CN1166379C Medicine for treating kidney disease and method for preparing same |
| 09/15/2004 | CN1166365C Alendronic-acid medicind composition and use of same for preparing medictne for inhibiting bone resorption of humanbody |
| 09/14/2004 | US6790953 Ether compounds |
| 09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790843 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 09/14/2004 | US6790631 For diagnosis and therapy of prostate cancer; qualitative analysis |
| 09/14/2004 | US6790464 Administering radix, medulla, rhizoma, cortex, olibanum, herba, fructus, folium, semen, poria, stigma, and/or phaseolus plant extract; anticarcinogenic, antitumor, and antimetabolic agents |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/10/2004 | WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
| 09/10/2004 | WO2004075893A1 Method of treatment of cardiac and/or renal failure using a calcium channel blocker and an angiotensin converting enzyme inhibitor or an angiotensin ii receptor blocker |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/09/2004 | US20040176466 an effective amount of atomoxetine in combination with an inhibitor of Cytochrome P450s for patients who are extensive metabolizers; administering to a patient who has previously not responded to attention-deficit/hyperactivity disorder treatment |
| 09/09/2004 | US20040176461 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176439 coadministration of agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F) |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176310 Use of extracts and preparations from iris plants and tectorigenin as medicaments |
| 09/09/2004 | US20040176297 Characterizing and predicting responses; identifying most efficient, cost effective and/or convenient treatment regimens; computer profiling |
| 09/09/2004 | US20040175370 Injecting aqueous solution containing an expression vector comprising desired gene; gene therapy wherein hepatocyte growth factor (HGF) gene is introduced by electroporation into kidney to be transplanted |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1454625A1 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453859A2 Chemically-modified human growth hormone conjugates |
| 09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
| 09/08/2004 | EP1453849A2 Antisense modulation of purinoreceptor p2x3 |
| 09/08/2004 | EP1453828A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome |